Drug Profile
Pregabalin controlled release - Ildong Pharmaceutical
Alternative Names: Pregabalin CR - Ildong Pharmaceutical; Pregabalin SR - Ildong PharmaceuticalLatest Information Update: 31 Dec 2021
Price :
$50
*
At a glance
- Originator Ildong Pharmaceutical
- Class Aminobutyric acids; Analgesics; Antiepileptic drugs; Anxiolytics; Gabapentinoids; Neuroprotectants; Small molecules
- Mechanism of Action CACNA2D1 protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Neuropathic pain
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for phase-I development in Neuropathic-pain in South Korea (PO, Controlled release)
- 01 Jun 2013 Ildong Pharmaceutical completes a phase I trial in healthy volunteers in South Korea (NCT02103647)
- 01 Jan 2013 Ildong Pharmaceutical completes a phase I trial in healthy volunteers in South Korea (NCT02103686)